Mangalam Drugs and Organics Limited announced key changes following a Board of Directors meeting held on February 6, 2026. The Board accepted the resignation of Shri Rukmesh P. Dhandhania, Independent Director, effective January 16, 2026. Mr. Jeevan M. Dalvi has been appointed as the Chief Financial Officer (CFO) of the company, also effective February 6, 2026. Mr. Dalvi is a Commerce graduate with over two decades of experience in accounts and finance, specializing in financial advisory, cost-saving measures, and improving financial processes. Furthermore, the Board approved the re-appointment of Dr. Praveen Saxena as an Independent Director for a second term of five years. This re-appointment is scheduled to commence on March 21, 2026, and will extend until March 20, 2031, subject to shareholder approval via a Special Resolution. Dr. Saxena is an international expert with extensive experience in energy policy, renewable energy development, and has numerous research publications and international accolades.
